FacebookTwitterYoutubeInstagramGoogle Plus

Game Change – CRISPR’s Brave New World

Just a handful of technologies deserve to be called “game changers”—and CRISPR-Cas9, the new gene-editing tool, is one of them. Discovered just three years ago, CRISPR is sweeping through labs around the world and researchers are already using it to experiment on diseases like cancer and AIDS, engineer new sources of clean energy, and create hardier plants and animals with the goal of wiping out world hunger. This Salon gathers bioengineers and medical researchers to take a hard look at the monumental changes hovering on the horizon.

View Additional Video Information


Robert BenezraCancer Biologist

Robert Benezra received his PhD at Columbia University before becoming a postdoctoral fellow at the Fred Hutchinson Cancer Center. There Dr. Benezra identified the Id proteins that are naturally occurring antagonists of other proteins that stimulate development and the cessation of cell growth in a variety of tissue types.

Read More


Jacob S. SherkowLaw Professor

Jacob S. Sherkow is an associate professor of Law at the Innovation Center for Law and Technology at New York Law School, where he teaches a variety of courses related to intellectual property. His research focuses on how scientific developments affect patent law and litigation.

Read More
Ben MatthewsBiologist

Ben Matthews is a postdoctoral research associate in the Laboratory of Neurogenetics and Behavior at The Rockefeller University and Howard Hughes Medical Institute. He joined the laboratory, run by Leslie Vosshall, in 2010 to study the mosquito Aedes aegypti, a vector of mosquito-borne diseases including Zika virus, Dengue Fever, and Chikungunya.

Read More
Neville SanjanaBioengineer, Neuroscientist

Neville Sanjana is a Core Faculty Member and Assistant Investigator at the New York Genome Center and an Assistant Professor in the Department of Biology and the Center for Genomics and Systems Biology at NYU.

Read More
Stephen TsangClinician-scientist

Stephen Tsang is the László Bitó Associate Professor in Ophthalmology, Pathology & Cell Biology at Columbia University and an attending ophthalmologist at New York-Presbyterian Hospital. He has been culturing embryonic stem (ES) cells since 1992.

Read More
Ellen JorgensenMolecular Biologist

Ellen Jorgensen is a molecular biologist and a passionate advocate of citizen science. Her research interests have encompassed such diverse areas as free radicals in disease, DNA fingerprinting, virus protein structure/function relationships, and cancer biomarkers.

Read More



Leave a Reply

Your email address will not be published. Required fields are marked *


View More Comments
Load More